Comparative Pharmacology
Head-to-head clinical analysis: CHG SCRUB versus EXIDINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHG SCRUB versus EXIDINE.
CHG SCRUB vs EXIDINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chlorhexidine gluconate disrupts bacterial cell membranes, leading to leakage of intracellular contents and cell death. It also binds to proteins and inhibits bacterial enzymes.
EXIDINE (chlorhexidine gluconate oral rinse) is a cationic bisbiguanide antiseptic that disrupts microbial cell membranes by binding to negatively charged bacterial cell walls, causing leakage of intracellular components and cell death.
Apply 5 mL to wet skin, scrub for 2 minutes, rinse thoroughly. Use undiluted.
Apply topically to affected area once or twice daily; oral rinse: 10 mL of 0.05% solution for 30 seconds twice daily (dilute 15 mL of 1% solution in 15 mL water if using concentrate).
None Documented
None Documented
Clinical Note
moderateLofexidine + Etacrynic acid
"The risk or severity of adverse effects can be increased when Lofexidine is combined with Etacrynic acid."
Clinical Note
moderateLofexidine + Furosemide
"The risk or severity of adverse effects can be increased when Lofexidine is combined with Furosemide."
Clinical Note
moderateLofexidine + Bumetanide
"The risk or severity of adverse effects can be increased when Lofexidine is combined with Bumetanide."
Clinical Note
moderateLofexidine + Unoprostone
Approximately 2 hours (terminal); prolonged in renal impairment.
Terminal half-life is approximately 14 hours, supporting twice-daily dosing for maintenance of therapeutic levels.
Primarily renal (90% unchanged); <5% biliary/fecal.
Primarily renal (unchanged drug and metabolites); approximately 70% excreted in urine, 30% in feces.
Category C
Category C
Antiseptic
Antiseptic
"Lofexidine may increase the hypotensive activities of Unoprostone."